Megan Melody, Malignant Hematologist – Lymphoma and Cellular Therapy at Tampa General Hospital and Assistant Professor at Morsani College of Medicine, shared a post on LinkedIn about a paper she co-authored with colleagues published in Blood Advances:
“Excited to share our most recent publication from the ABC Consortium in Blood Advances!
We report outcomes of bispecific antibodies following CAR T-cell therapy in LBCL, shedding light on how we can optimize treatment beyond CAR T. Proud to contribute to this growing field and collaborate with incredible colleagues through the ABC.
Read the full article.”
Title: Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma – Results from the ABC Consortium
Authors: Megan Melody, Natalie S. Grover, Stephanie Franco, Jason T. Romancik, Matthew J. Cortese, Tamara K Moyo, Rahul S Bhansali, Thomas A Ollila, Vaishalee P Kenkre, Lindsey A. Fitzgerald, Brian T Hess, Matthew J. Matasar, Geoffrey Shouse, Kaitlin Annunzio, Megan M. Herr, James A Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Shuo Ma, Jane N Winter, Adam Yuh Lin, Alexey V Danilov, Ishan Roy, Stefan K. Barta, Leo I. Gordon, Deborah M Stephens, Jonathon B Cohen, Narendranath Epperla, Reem Karmali
You can read the Full Article in Blood Advances.
More posts featuring Megan Melody.